… after neoadjuvant chemotherapy (NACT) are still under investigation. The aim of this study
was to compare CA125 and HE4 … Serum HE4 and CA125 samples were taken at the time of …

… In this study, we first aimed to evaluate serum HE4 changes during NACT and to find a
predebulking surgery cutoff value that is able to predict complete cytoreduction. The secondary …

… of serum human epididymis protein 4 (HE4) and HE4 tissue protein expression to predict
tumor resistance to adjuvant chemotherapy, … impossible, neoadjuvant chemotherapy (NACT) …

… Serum HE4 levels were independently associated with TR among patients with AOEC
treated with NACT, also a reduction between baseline HE4 and first chemotherapy levels was …

… In the neoadjuvant chemotherapy group, HE4 correlated better with the radiologic response
… of serum HE4 changes could improve the evaluation of response to chemotherapy in …

… ) of HE4 before and after neoadjuvant chemotherapy could predict optimal interval debulking
surgery. Serum HE4 … or percentage) of HE4 in neoadjuvant chemotherapy could predict the …

… treatment and 42 patients qualified for neoadjuvant chemotherapy. Each patient underwent
… A univariate logistic regression analysis showed that serum HE4 significantly correlated with …

… Serum HE4 is more specific than CA125 in discriminating … In addition to its diagnostic value,
the serum HE4 level may be … profile of the HE4 level during neoadjuvant chemotherapy (NAC…

… In our study, the mean value of HE4 in the group of patients radically operated at the moment
of diagnosis was 78.87 pmol/L and in the group treated with neoadjuvant chemotherapy …

… We evaluated serum CA125 and serum HE4 response after treatment completion in both …
and after neoadjuvant chemotherapy in the IDS group. We found that a >80% fall in serum HE4 …